NeuroBo Pharmaceuticals Sees Reporting Top-Line Data From Both Parts of Ongoing Phase 2a Clinical Trial in Mash in Q4 of This Year
NeuroBo Pharmaceuticals預計將在今年第四季度報告Mash正在進行的2a期臨床試驗的兩個部分的頂級數據
NeuroBo Pharmaceuticals Sees Reporting Top-Line Data From Both Parts of Ongoing Phase 2a Clinical Trial in Mash in Q4 of This Year
NeuroBo Pharmaceuticals預計將在今年第四季度報告Mash正在進行的2a期臨床試驗的兩個部分的頂級數據
譯文內容由第三人軟體翻譯。